$3.96
0.030.76%
In chiusura: Nov 20, 4:00 PM EST
$3.97
0.010.25%
Post-mercato: Nov 20, 4:00 PM EST

The average analyst price target for Atea Pharmaceuticals is $9, 126.7% above the current price. The one analyst covering it rates it Outperform. Targets range from $8 to $10. The latest change came on Nov 16, 2026, when Morgan Stanley raised its price target on Atea Pharmaceuticals from $7 to $8 and kept an Equal-Weight rating.
Price Target Range — 5 Quarters
Analyst Consensus — 1 Analysts
Rating Trend — Last 9 Months